2019 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma | 김휘영 | Review |
2020 | A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function | 백승연; 유권; 이정경; 김태헌; 최선영; 김휘영; 이혜아; 남준열; 최아름 | Article |
2018 | A Model for Adaptive Decision Making of 'Ablate-and-Wait' Versus Transplantation in Patients with Hepatocellular Carcinoma | 김희영; 김휘영 | Article |
2016 | A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort Study | 김휘영 | Meeting Abstract |
2016 | A Novel Biomarker-Based Model for the Prediction of Response to Sorafenib and Overall Survival for Advanced Hepatocellular Carcinoma: A Prospective Cohort Study | 김휘영 | Meeting Abstract |
2022 | An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B | 김휘영 | Article |
2022 | Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study | 김휘영 | Article |
2024 | Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma | 김휘영; 이혜아 | Article |
2023 | Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수 | Article |
2021 | Association of physical activity with the risk of hepatocellular carcinoma in patients with chronic hepatitis b | 유권; 김태헌; 김휘영; 이민종; 최아름 | Article |
2023 | Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification | 김휘영; 이혜아 | Article |
2022 | Body Components at Baseline and Their Early Changes Predict Development and Resolution of Metabolic Associated Fatty Liver Disease | 임지영 | Doctoral Thesis |
2016 | Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome | 김휘영 | Article |
2016 | Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism | 김휘영 | Article |
2016 | Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis | 김휘영 | Article |
2016 | Comparative effectiveness of lamivudine versus entecavir in patients with hepatocellular carcinoma: Watch out for confounders! | 김휘영 | Editorial |
2017 | Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions | 김희영; 김휘영 | Review |
2018 | Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality | 김휘영 | Article |
2021 | Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression | 김휘영 | Article |
2021 | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | 김휘영 | Article |
2020 | Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study | 김휘영 | Article |
2023 | Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial | 김유리; 김휘영; 이혜아; 이한아 | Article |
2024 | Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort study | 김휘영 | Article |
2018 | Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial | 김휘영 | Article |
2019 | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects | 김형래; 유권; 김태헌; 윤여준; 김휘영; 이은주 | Article |
2015 | Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay | 김휘영 | Article |
2024 | Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma | 김태헌; 김휘영; 이민종; 전호수; 이한아 | Article |
2022 | Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | 김휘영 | Article |
2018 | Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area | 김휘영 | Article |
2014 | MicroRNA-196A-2 Polymorphisms and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B | 김휘영 | Article |